Introduction: The aim of the study was to evaluate and compare the efficacy, side effects and recurrence rate of vernal kerato conjunctivitis (VKC) with 0.03% tacrolimus and 0.05% cyclosporin.
Material And Method: A prospective randomised double blinded comparative study was conducted at a tertiary eye center. 46 Patients of VKC between March 2015- August 2015 were randomly divided into two groups and treated for 6weeks with either Tacrolimus(0.03%) eye ointment BD or Cyclosporine (0.05%) eyedrops QID.The main outcome measures were scoring and comparison of Total subjective symptom scores (TSSS) and Total objective ocular sign scores (TOSS) within and between the Groups at each follow up.Thirty two patients, sixteen from each group, with comparable baseline characters were analysed.
Results: With treatment both TSSS and TOSS decreased consistently in both groups without any adverse effects but an increase in scores was noticed within two weeks after drug withdrawal.
Conclusion: Both drugs are equally effective and safe in VKC but with short lasting effect.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3126/nepjoph.v9i2.19257 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Howell-Jolly Body-Like Neutrophil Inclusions Following Hematopoietic Stem Cell Transplantation: A Case Report.
Am J Case Rep
December 2024
Department of Clinical Laboratory, Aerospace Center Hospital, Beijing, China.
BACKGROUND In several studies, the presence of Howell-Jolly body-like inclusions within neutrophils has been observed in cases of HIV infection, SARS-CoV-2 infection, post-transplant immunosuppression, and during chemotherapy or antiviral therapy. The phenomenon of neutrophils exhibiting Howell-Jolly body-like inclusions on peripheral blood smears can be attributable to viral infections or the pharmacological effects of medications. CASE REPORT A 14-year-old male patient who had received a diagnosis of lymphoblastic leukemia a year ago underwent hematopoietic stem cell transplantation and was readmitted due to a recurrence of gastrointestinal graft-versus-host disease (GVHD).
View Article and Find Full Text PDFBelumosudil in pediatric patients with chronic graft-versus-host disease after failed multi-line therapy: a case series.
Ann Hematol
December 2024
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Belumosudil is a selective small molecule inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2) indicated for patients with glucocorticoid-refractory chronic graft-versus-host disease (cGVHD). Despite its approval for ages 12-18, there is limited pediatric data available. This case series presents three 12-year-old patients with severe cGVHD who had failed multiple lines of therapy.
View Article and Find Full Text PDFImpact of Cold Ischemia Time and Donor Age on Donation After Circulatory Death Kidney Transplant Outcomes: A UNOS Mate-Kidney Analysis.
Clin Transplant
December 2024
Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Article Synopsis
- - The study investigated the impact of prolonged cold ischemia times (CIT) and donor age on kidney transplant outcomes for recipients of kidneys from donors after circulatory death (DCD), utilizing a large dataset from 2010-2024.
- - Analysis of 4092 mate-kidney pairs showed no significant differences in patient death or allograft failure between kidneys with CITs greater than 24 hours and those with shorter CITs.
- - Prolonged CITs were linked to a higher likelihood of delayed graft function (DGF), suggesting that accepting kidneys with longer CITs should still be considered despite the associated risks.
Relationships Between Tacrolimus Exposure and Adverse Events in Renal Transplant Patients: The ExpoTac Study.
Ther Drug Monit
December 2024
Service de Pharmacologie, toxicologie et pharmacovigilance, CHU Limoges, Limoges, France.
In transplantation, the association of tacrolimus exposure with efficacy is better known than with adverse effects. The ExpoTac study explored the relationships between tacrolimus exposure and adverse events (AEs) in kidney transplant patients who benefited from at least 3 measurements of tacrolimus area under the curve (AUC) within 2 years of transplantation. The relationships between tacrolimus AUC, trough concentration C0, peak concentration Cmax, and AEs were explored using univariate analysis and Cox models in 386 patients (1281 sets of exposure biomarkers).
View Article and Find Full Text PDF[Innovative Personalized Medicine for Immunosuppressive Drugs Based on Novel Control Theory of Pharmacokinetics].
Yakugaku Zasshi
December 2024
Department of Pharmacy, University of Miyazaki Hospital.
Tacrolimus is widely recognized as an anti-rejection agent due to its immunosuppressive characteristics. It binds to the immunophilin FK506-binding protein (FKBP) and thus to calcineurin, and inhibits its activity. Tacrolimus' therapeutic concentration range in blood is narrow, and its pharmacokinetics are highly variable among individuals.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!